A year after the nation's first nonprescription daily birth control pill debuted for sale, reproductive health advocates said its impact has been felt especially by young womenwho now can easily obtain such contraception on store shelves and online without fear and shame that can accompanysuch choices.
Opill, manufactured by Perrigo Company, is a hormonal birth control medication the U.S. Food and Drug Administration approved in July 2023 to be sold over the counter before the rollout to consumers last March.
The company didn't release specific sales data but said Monday in a statementthat sales of Opill "have grown on a weekly basis" and there is"an approximate 50% repeat rate" for purchases and use.
Opill is madeofprogestin, and according to the FDA, is amedicationthat has been considered safe for more than 50 years, withclinical trials showing it is 98% effective when taken daily at the same time. Theagencydidn't immediately respond Monday to an inquiry asking about Opill's impact in the last year.
The FDA has said while Opill'seffectiveness is lower in real-life settings due to human error, it is believed to be more effective than other nonprescription contraceptive methods, such as condoms, spermicide and sponges.
Victoria Nichols, project director at Free the Pill coalition, which includes more than 200 reproductive health, rightsand justice groups, saidthe FDA’s approval to allow Opill to be sold over the counter was a "historic achievement" that has expanded "critical" reproductive health access in the past year.
The United States joined 100 other nations that currently makebirth control pills available without the need for a prescription, Nichols said. The Free the Pill coalition, operated by Ibis Reproductive Health, is an international nonprofit thatwas instrumental in pushing for federal authorization.
"This is a massive step forward," Nicholssaid of the impact a year later.
Expanding access to reproductive options is critical at a time when states are restricting abortions, some reproductive health advocates and medical experts said.In 2022, the U.S. Supreme Court overturned constitutional abortion protectionestablished in its landmark Roe v. Wade 1973 decision.
Twelve states have a total ban on abortion in place, according to Guttmacher Institute, a nonprofit research and policy organization focused on advancing sexual and reproductive health and rights.
More access to birth control also is important at a time whenimmigrant populations may beavoiding medical care due to fears of deportation or arrest, some ofthe expertssaid.
Angela Maske, strategic projects manager at Washington, D.C.-based Advocates for Youth, a nonprofit,saidyoung people face numerous challenges accessingbirth control.
Hurdlesinclude being scared to tell their family they are sexually active, along with theinability to schedule medical appointments due to being uninsured orintimidated. Other issues include being unable to take time off from work or school to get to doctor appointments and having no easy way to get there, according to Maske and other reproductive health and justice groups. They said the OTC pill's availability has helpedliftsome of those barriers.
Rochelle Rodney, co-executive director of New York Birth Control Access Project, said young people throughout New York and across the countryhistorically have dealt with "stigma and shame" when it comes to their sexual health. Young people, she said, now are relieved to have the ease and convenience of either ordering birth control pills online or privately grabbing them off a store shelf.
"They've been raving about not having to set an appointment with a doctor and go through tons of conversations and counseling when they have already decided that they wanted to try itor they have already been on contraceptive pills," Rodney said in an interview.
Some experts said the pill's expanded availability also benefits other women, like those who havelow income or lack health insurance.
Across the country, more than 19 million women of reproductive agelive in "contraceptive deserts," meaning they "lack reasonable access in their county to a health center that offers the full range of contraceptive methods,"according to a 2023 report by Power to Decide, a nonprofit that advocates for reproductive health. The report also foundmore than 1.2 millionwomen in New York State live in counties that lack the full range of availablecontraceptive methods.
"In New York State, we have less contraceptive providers per capita than most other states ... so access without a doctor's appointment is crucial," Rodney added.
In January, the U.S. Department of Homeland Security rescinded a 2021 policy that limited Immigration and Customs Enforcement agents "to the fullest extent possible" from going intoa"protective area" like a hospital, school or churchto take enforcement action.
"There arejust a lot of fears and a lot of uncertainty, and so I think that in this moment, it's very important that there is a reliable option for people that they know they won't necessarily have to interface with the health system," said Maske, from Advocates for Youth.
Dr. Leah Kaufman, an associate professor in the Division of Obstetrics and Gynecologyat Stony Brook Medicine,said the timing could benefit people who are afraid to seek care in traditional medical settings.
"Currently we have many patients who are fearing coming into the medical community for a lot of different reasons. They should also have access to control over reproductive choice and timing," said Kaufman.
"Thankfully, in New York State, access to abortion is an option and abortion is legal, but that's not the case in all states, and the best option always is for women to have that control over timing and to be able to have access to safe contraception," Kaufmanadded.
But awareness of this first-in-the-nation contraception optionremains low, according to one recent survey.
Health research group KFF found in itsWomen's Health Surveyin Novemberthatonly 26% of women aged 18 to 49,out of 3,901 women polled,said they have heard of Opill.
At least one religious organization wascritical of the FDA's decision to approve Opill. The U.S. Conference of Catholic Bishops released a statement at that timesaying: "This action by a government entity flies in the face of responsible medical practice and concerns for women’s health. Claims that the benefits of this action outweigh the risks are unfounded, especially in light of strong evidence of the many harmful risks of hormonal contraception to women’s health."
The organization didn't immediately respond to a request for comment Monday.
Dr. Monique De Four Jones, theassociate chief of labor and delivery at Long Island Jewish Medical Center, recently recalledpublicity last year surroundingOpill's entry into the over-the-counter retail market.
"Then it kind of got forgotten," De Four Jones added in an interview, while recalling her 27-year-old daughter recently pointing itout ina store.
The drug, whichaccording to the FDA shouldn't beused by people who had or have breast cancer or be used in conjunction with another hormonal birth control product, costs $20 a month.
"The availability is nice for people, because they're able to go to the pharmacyor ...log on to the computer and get their birth controlsent to them without a hassle," De Four Jonessaid.
A year after the nation's first nonprescription daily birth control pill debuted for sale, reproductive health advocates said its impact has been felt especially by young womenwho now can easily obtain such contraception on store shelves and online without fear and shame that can accompanysuch choices.
Opill, manufactured by Perrigo Company, is a hormonal birth control medication the U.S. Food and Drug Administration approved in July 2023 to be sold over the counter before the rollout to consumers last March.
The company didn't release specific sales data but said Monday in a statementthat sales of Opill "have grown on a weekly basis" and there is"an approximate 50% repeat rate" for purchases and use.
Opill is madeofprogestin, and according to the FDA, is amedicationthat has been considered safe for more than 50 years, withclinical trials showing it is 98% effective when taken daily at the same time. Theagencydidn't immediately respond Monday to an inquiry asking about Opill's impact in the last year.
WHAT NEWSDAY FOUND
- A year after sales started in March 2024, reproductive health advocates saidthe nation’s first nonprescription daily birth control pill has made it easier foryoungwomen to take control of theirhealth.
- Those advocates and some medical expertssaid Opill's expanded availability also benefits other women, like those who have low income or lack healthinsurance.
- The drug,whichaccording to the FDA shouldn't beused by people who had or have breast cancer or be used in conjunction with another hormonal birth control product, costs $20 a month.
The FDA has said while Opill'seffectiveness is lower in real-life settings due to human error, it is believed to be more effective than other nonprescription contraceptive methods, such as condoms, spermicide and sponges.
Sign up for the Health newsletter
Get the latest stories every week about health and wellness, covering topics from medicine and mental health to updates on the coronavirus and new research.
By clicking Sign up, you agree to our privacy policy.
Victoria Nichols, project director at Free the Pill coalition, which includes more than 200 reproductive health, rightsand justice groups, saidthe FDA’s approval to allow Opill to be sold over the counter was a "historic achievement" that has expanded "critical" reproductive health access in the past year.
The United States joined 100 other nations that currently makebirth control pills available without the need for a prescription, Nichols said. The Free the Pill coalition, operated by Ibis Reproductive Health, is an international nonprofit thatwas instrumental in pushing for federal authorization.
"This is a massive step forward," Nicholssaid of the impact a year later.
Expanding access to reproductive options is critical at a time when states are restricting abortions, some reproductive health advocates and medical experts said.In 2022, the U.S. Supreme Court overturned constitutional abortion protectionestablished in its landmark Roe v. Wade 1973 decision.
Twelve states have a total ban on abortion in place, according to Guttmacher Institute, a nonprofit research and policy organization focused on advancing sexual and reproductive health and rights.
More access to birth control also is important at a time whenimmigrant populations may beavoiding medical care due to fears of deportation or arrest, some ofthe expertssaid.
'Contraceptive deserts'
Angela Maske, strategic projects manager at Washington, D.C.-based Advocates for Youth, a nonprofit,saidyoung people face numerous challenges accessingbirth control.
Hurdlesinclude being scared to tell their family they are sexually active, along with theinability to schedule medical appointments due to being uninsured orintimidated. Other issues include being unable to take time off from work or school to get to doctor appointments and having no easy way to get there, according to Maske and other reproductive health and justice groups. They said the OTC pill's availability has helpedliftsome of those barriers.
Rochelle Rodney, co-executive director of New York Birth Control Access Project, said young people throughout New York and across the countryhistorically have dealt with "stigma and shame" when it comes to their sexual health. Young people, she said, now are relieved to have the ease and convenience of either ordering birth control pills online or privately grabbing them off a store shelf.
"They've been raving about not having to set an appointment with a doctor and go through tons of conversations and counseling when they have already decided that they wanted to try itor they have already been on contraceptive pills," Rodney said in an interview.
Some experts said the pill's expanded availability also benefits other women, like those who havelow income or lack health insurance.
Across the country, more than 19 million women of reproductive agelive in "contraceptive deserts," meaning they "lack reasonable access in their county to a health center that offers the full range of contraceptive methods,"according to a 2023 report by Power to Decide, a nonprofit that advocates for reproductive health. The report also foundmore than 1.2 millionwomen in New York State live in counties that lack the full range of availablecontraceptive methods.
"In New York State, we have less contraceptive providers per capita than most other states ... so access without a doctor's appointment is crucial," Rodney added.
'A lot of fears'
In January, the U.S. Department of Homeland Security rescinded a 2021 policy that limited Immigration and Customs Enforcement agents "to the fullest extent possible" from going intoa"protective area" like a hospital, school or churchto take enforcement action.
"There arejust a lot of fears and a lot of uncertainty, and so I think that in this moment, it's very important that there is a reliable option for people that they know they won't necessarily have to interface with the health system," said Maske, from Advocates for Youth.
Dr. Leah Kaufman, an associate professor in the Division of Obstetrics and Gynecologyat Stony Brook Medicine,said the timing could benefit people who are afraid to seek care in traditional medical settings.
"Currently we have many patients who are fearing coming into the medical community for a lot of different reasons. They should also have access to control over reproductive choice and timing," said Kaufman.
"Thankfully, in New York State, access to abortion is an option and abortion is legal, but that's not the case in all states, and the best option always is for women to have that control over timing and to be able to have access to safe contraception," Kaufmanadded.
But awareness of this first-in-the-nation contraception optionremains low, according to one recent survey.
Health research group KFF found in itsWomen's Health Surveyin Novemberthatonly 26% of women aged 18 to 49,out of 3,901 women polled,said they have heard of Opill.
At least one religious organization wascritical of the FDA's decision to approve Opill. The U.S. Conference of Catholic Bishops released a statement at that timesaying: "This action by a government entity flies in the face of responsible medical practice and concerns for women’s health. Claims that the benefits of this action outweigh the risks are unfounded, especially in light of strong evidence of the many harmful risks of hormonal contraception to women’s health."
The organization didn't immediately respond to a request for comment Monday.
Dr. Monique De Four Jones, theassociate chief of labor and delivery at Long Island Jewish Medical Center, recently recalledpublicity last year surroundingOpill's entry into the over-the-counter retail market.
"Then it kind of got forgotten," De Four Jones added in an interview, while recalling her 27-year-old daughter recently pointing itout ina store.
The drug, whichaccording to the FDA shouldn't beused by people who had or have breast cancer or be used in conjunction with another hormonal birth control product, costs $20 a month.
"The availability is nice for people, because they're able to go to the pharmacyor ...log on to the computer and get their birth controlsent to them without a hassle," De Four Jonessaid.
By Lorena Mongelli
lorena.mongelli@newsday.com
